Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study

Treatment options for Hepatitis C infection have greatly improved with direct-acting antiviral (DAA) combinations achieving high cure rates. Nevertheless, the cost of this treatment is still high and access to treatment in many countries has been preferentially reserved for patients with more severe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Epidemiol Infect
Main Authors: Semenova, T., Nemoz, B., Thibault, V., Lagathu, G., Duverlie, G., Brochot, E., Trimoulet, P., Payan, C., Vallet, S., Henquell, C., Chevaliez, S., Bouvier-Alias, M., Maylin, S., Roque-Afonso, A-M., Izquierdo, L., Lunel-Fabiani, F., Marcellin, P., Morand, P., Leroy, V., Larrat, S.
Format: Artigo
Jezik:Inglês
Izdano: Cambridge University Press 2019
Teme:
Original Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625182/
https://ncbi.nlm.nih.gov/pubmed/31364570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268819001225
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki